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ABSTRACT 
Microemulsions (MEs) are clear, thermodynamically stable systems. They were used to solubilise drugs and to improve topical drug availabilit y. 
Salicylic acid (SA) is a keratolytic agent used in topical products with antimicrobial actions. This study aimed to formulate an optimized SA 
micro emulsion gel for the slow, variable and incomplete oral drug absorption in patient suffering from psoriasis infection. The dispersion 
solubility of SA was studied in various oils, surfactants and co-surfactants and by constructing pseudo phase ternary diagram, micro emulsion 
area was identified. The optimized formulations of micro emulsion were subjected to thermodynamic stability tests. After stab ility study, stable 
formulation was characterized for droplet size, pH determination, centrifugation, % drug content in micro emulsion, zeta Potential and vesicle 
size measurement and then micro emulsion gel were prepared and characterized for spreadability, measurement of viscosity, drug content, In-
vitro diffusion, in-vitro release data. Labrasol was selected as surfactant, plurol oleique as co surfactant and neem oil as oil component based on 
solubility study. The optimized formulation contained SA 0.05 (%w/w), labrasol (24%), plurol oleique (8 %) and neem oil (8%). The in vitro 
drug release from SA micro emulsion gel was found to be considerably higher in comparison to that of the pure drug. The in-vitro diffusion of 
micro emulsion gel was significantly good. Based on this study, it can be concluded the solubility and permeability of SA can be increased by 
formulating into micro emulsion gel.  
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INTRODUCTION 
Psoriasis is a common, chronic, non-contagious, auto-
immune disease that primarily affects the skin and seen in 
about 2-3% of population world-wide1. The word psora 
comes from Greek word which means to itch. Psoriasis, a 
term which has been in use since 133 AD, was originally 
grouped with leprosy until the 19th century. It has been 
suggested that biblical leprosy was in fact, the disorder 
known today as psoriasis2. It is mostly an inheritant disease, 
characterized by scaly, red and itchy plaques. The most 
commonly affected areas are the entire scalp and can also 
spread to the forehead, back of neck or behind ears, chest, 
arms, elbows, in the armpits, under the breasts, around the 
genitals, knees, legs, toenails and fingernails3. It affects males 
and females equally and also affects children, adult, older 
peoples and may occur at any age of life. It is more common 
in people between the ages of 15 and 35, According to 
National Psoriasis Foundation. Psoriasis is partly due to 
genetic and partly due to environmental factors4. Psoriasis 
can be categorized as mild, moderate and severe. Mild 
psoriasis leads to formation of rashes and when it becomes 
moderate the skin turns scaly. In severe conditions, the red 
patches may be present on skin surface and become itchy. 
This affects a person’s professional and social life. The 
normal mechanism of body is to form new skin cells every 
month to replace the skin which is shed off. But, in psoriasis 
the new skin cells grow rapidly within days rather than 
weeks. This leads to accumulation of dead skin on the skin 
surface resulting in thick patches of red, dry and itchy skin5. 
Microemulsions (MEs) are clear, thermodynamically stable, 
optically isotropic systems. They are formed spontaneously 
upon mixing a suitable oil, water, and an amphiphile blend 
(surfactants either alone or in combination with a 
cosurfactant 6-9. MEs offer advantages over traditional 
creams and lotions as topical drug delivery. They were used 
to solubilize drugs and to improve topical drug availability10. 
They are able to increase the rate and depth of moisturizing 
agents into skin. It has been suggested that MEs may dissolve 
the ordered structure of the stratum corneum lipids, leading 
to the loss of barrier properties of the skin11. Salicylic acid 
(SA) is a white fluffy crystalline powder, slightly soluble in 
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water (1 in 460 ml). It is used as keratolytic agent in topical 
products, and it has antimicrobial and fungicidal actions12-14. 
Antibacterial activity of SA was recorded by Park et al15and 
Kupferwasser et al16 as adjuvant therapeutic agent in 
treatment of Staphylococcus aureus infections. SA is used 
topically in hyperkeratotic and scaling conditions to enhance 
the rate of loss of surface scales17. The side effects of SA 
include sensitivity, excessive drying, and irritation. 
Traditional formulations of SA in ointment bases have 
disadvantages of being greasy and irritant due to free 
crystals of the drug. In this study, SA was incorporated with 
different concentrations in an ME gel base. Characterization 
of the prepared systems was carried out by applying 
different evaluation tests to examine the effect of 
incorporation of the drug on the ME gel base. 
MATERIALS AND METHODS 
Salicylic acid was obtained as a gift sample from Macleods 
pharmaceuticals, Mumbai. Labrasol, Plurol Oleique was 
obtained from Gattefosse India Pvt. Ltd., Mumbai, India. 
Neem oil from Gogia Chemicals, Noida, India, All other 
surfactant and co surfactant were purchased from Hi Media 
and S. D. Fine Chem. Ltd., Mumbai. Double distilled water was 
prepared freshly and used whenever required. All other 
chemicals used in this study including those stated were of 
analytical reagent (A.R.) grade. 
Solubility studies 
Solubility determination in the various oils, surfactants and 
co-surfactants for formulating micro emulsion drug delivery 
system. The solubility of the drug in different oils is an 
essential step for the micro emulsion formulation. So before 
starting the phase diagram one must have to select the oil, 
surfactant and co-surfactant in which the drug shows 
maximum solubility, to be in the desired solubility range, 
which is essential for the formulation of micro emulsion drug 
delivery system. Drug powder of SA was added in excess to 
each of the oils, surfactants (S), cosurfactants (CoS) and then 
vortexed for mixing. After vortexing the samples were kept 
for 72 hours at ambient temperature for attaining 
equilibrium. The equilibrated samples were then centrifuged 
at 5000 x g for 30 minutes to remove the undissolved drug18, 
19. 
Pseudo-ternary phase diagram 
In order to find out the concentration range of components 
for the existing range of microemulsion (ME), pseudo-
ternary phase diagrams were constructed using water 
titration method (1,5) at ambient temperature. Three phase 
diagrams were prepared with the 1:1, 2:1 and 3:1 weight 
ratios of mixture of Labrasol® (LAB) and Neem Oil (PO), 
respectively. For each phase diagram at a specific S/CoS 
mixing ratio (Km), the ratios of oil to the mixture of S/CoS 
(Smix) were varied as 1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9:1. 
Water was added drop by drop, under gentle agitation, to 
each oily mixture. Usually, after the clear mixture became 
turbid at a certain point (beginning of phase inversion area), 
the turbid mixture turned to be clear (beginning of O/W ME 
area) and, then, finally turbid once again (end of O/W ME 
area) with the continuous addition of water. The experiment 
was repeated for each S/CoS (1, 2 and 3). Based on these 
results, appropriate concentrations of oil, surfactant and 
cosurfactant were selected and used in the preparation of 
microemulsions (MEs) containing SA. During the titration, 
samples were stirred vigorously for a sufficient length of 
time for homogenization and the end product was visually 
monitored against a dark background by illuminating the 
samples with white light After being equilibrated at ambient 
temperature for 24 hours, the mixtures were assessed 
visually and determined as being ME, crude emulsions or ME 
gels. The stable MEs were also observed under polarizing 
light to conform their isotropic nature. Gels were claimed for 
those clear and highly viscous mixtures that did not show a 
change in the meniscus after tilted to an angle of 90°. 
Formation spontaneity of ME was evaluated by the addition 
of known amount of water at once to the known amount of 
oil, surfactant and secondary surfactant with controlled 
stirring. The ease of formation of clear ME was taken as the 
criteria of spontaneity. 
Preparation of microemulsions 
For further studies, from the constructed pseudotemary 
phase diagram, Neem oil (NO)/LAB/PO mixture with 
oil/Smix 0.250 was selected. Furthermore, six potential ME 
vehicles different from each other by water volume fraction, 
were selected and prepared at Km 3:1 and oil/Smix 0.250. 
The calculated amount of drug (0.05%w/w of SA) was added 
to the oily phase of ME and magnetically stirred until 
dissolved followed by addition of Smix in a fixed proportion 
to produce clear mixture. Then a defined proportion of water 
was added and stirred to produce clear ME of SA. Both, 
unloaded and drug-loaded MEs were prepared 48 h before 
investigations (we can reasonably assume that the drug 
distribution among the oil, water and surfactant micelles, 
attains the thermodynamic equilibrium) and stored at room 
temperature18, 20 Table 1. 
 
Table 1 Compositions of the selected microemulsion formulations  
Components Microemulsion 
ME1 ME2 ME3 ME4 ME5 ME6 
Neem oil (NO) 18 16 14 12 10 08 
Labrasol (LAB) 54 48 42 36 30 24 
Plurol Oleique    18  16     14       12    10     08 
Water 10 20 30 40 50 60 
 
Characterization of microemulsions 
The physico-chemical parameters of prepared MEs were 
determined as follow21-24. 
Particle size and zeta potential measurements 
The average droplet size and polydispersity index (PDI) of 
ME was measured by photon correlation spectroscopy (PCS) 
with in-built Zetasizer (Nano ZS, Malvern Instruments, UK) 
at 633 nm. Helium - neon gas laser having intensity of 4mW 
was the light source. The droplet size was calculated using 
Stokes-Einstein relationship by Zetasizer Software. 
Electrophoretic mobility (pm/s) was measured using small 
volume disposable zeta cell and converted to zeta potential 
by in-built software using Helmholtz-Smoluchowski 
equation. All determinations were made in triplicate. 
Determination of drug content 
For determination of drug content, about 1 g of the 
formulation was weighed in a 10-ml volumetric flask and 
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dissolved in methanol; it was diluted appropriately and 
analyzed by the UV spectroscopy method. 
pH measurement 
pH of the micro emulsion was measured using (Digital pH 
meter MK).The electrode was rinsed with deionized water 
and blot was dried with a soft, clean paper. Then the 
electrode was dipped into the test solution. Then pH was 
recorded when the reading was stable after insertion of the 
electrode into the solution. 
Conductivity measurement 
The electric conductivity of ME was measured with a 
conductivity meter (Equip-Tronics, EQ - 664, Mumbai, India) 
equipped with inbuilt magnetic stirrer. This was done by 
using a conductivity cell (with a cell constant of 1.0) 
consisting of two platinum plates separated by desired 
distance and having liquid between the platinum plate acting 
as a conductor. The electrode was calibrated before using it 
for sample determination using 0.1 N KC1 (7.456 gm of KC1 / 
1000 ml distilled water) having conductivity 0015.39 
mS/cm. 
Percent transmittance measurement 
The percent transmittance of the formulation was measured 
using a colorimeter (Digital Colorimeter, D-801, Photocon, 
India) at 570-590 nm. 
Viscosity measurement 
The viscosity of ME was measured using a Brookfield 
Viscometer LVDV IIIU (Brookfield Engineering LABS, 
Stoughton, USA) with spindle SC 18 at 100 rpm using interval 
of 30 seconds. The calibration of viscometer was verified 
using viscosity Fluid standard-General purpose silicone 
fluids - having viscosity 5000 cp. All aspects of testing were 
controlled using Rheocalc Software. 
Stability studies 
The stability of ME formulations was studied through various 
parameters such as clarity, phase separation observation, 
droplet size determinations, viscosity measurements, 
conductivity measurements, pH and zeta potential 
determinations for 6 months at room temperature. In order 
to estimate metastable systems, the selected ME vehicles 
were centrifuged (Remi Lab, Mumbai) at 3000 x g for 30 
minutes. Beside the physicochemical properties, the 
chemical stability of the investigated drug in the vehicle 
plays a major role. Therefore the drug content was analysed 
at defined time intervals during the observation period of 6 
months. During the observation period the formulations 
were stored at room temperature in tubes to simulate 
patient usage conditions25, 26. During stability studies the 
samples were taken at fixed time intervals. 
Formulation of microemulsion based gel of salicylic acid 
Various gelling agents namely hydroxypropyl 
methylcellulose (Methocel K4M) and non-benzene grade 
carbopol polymers (Carbopol 97IP NF, Carbopol 974P NF 
and Carbopol980P NF) were evaluated for their ability to gel 
optimized SA-MEs at different concentrations. The suitable 
gelling agent was selected on the basis of compatibility with 
MEs structure, feel and ease of spreadability. Carbopol 97IP 
NF was selected as the gel matrix to prepare MBG. Carbopol 
97 IP NF was slowly mixed with water. The oily phase was 
obtained by mixing appropriate concentrations of oil, 
surfactant and co-surfactant. Carbopol97 IP NF was entirely 
swelled in the water and its pH was adjusted by adding 
50%w/w triethanolamine (TEA). MBG was obtained by 
mixing the swelled gel in water with the oily phase Table 2. 
Table 2 Composition of microemulsion based gel 
containing salicylic acid 
Components Content 
Salicylic acid 0.05 (%w/w) 
Carbopol 971P NF (% w/w) 2 
Neem oil (% w/w) 8 
Labrasol (% w/w)               24 
Water (g) Quantity sufficient to 
produce 100 g of gel 
 
Characterization of microemulsion based gel of salicylic 
acid 
Determination of pH  
The pH of the 10% (w/w) gel was determined using digital 
pH meter (HI 98107, Hanna Instruments, India.), 
standardized using pH 4 and 7 buffers before use. 
Determination of spreadability  
The  spreadability  of the  gel  was determined  using  the  
following technique:  0:5  gm  gel was placed within a circle 
of 1cm diameter  premarked on a glass plate over which a 
second glass plate was placed. A weight of 500 gm was 
allowed to rest on the upper glass plate for 5min. The 
increase in the diameter due to spreading of the gels was 
noted and the mean diameter was taken by repeating the 
experiment three times.  
Determination of drug content  
For determination of drug content, about 1 gm of the gel was 
weighed in a 100-ml volumetric flask and dissolved in 
methanol; it was diluted appropriately and analyzed by UV. 
Drug content was calculated by linear regression analysis of 
the calibration curve. 
In-vitro diffusion study 
An in-vitro drug release study was performed using modified 
Franz diffusion cell. Dialysis membrane (Hi Media, Molecular 
weight 5000 Daltons) was placed between receptor and 
donor compartments. Nanoemulsion gel equivalent to 5mg of 
drug was placed in the donor compartment and the receptor 
compartment was filled with phosphate buffer, pH 7.4 (24 
ml). The diffusion cells were maintained at 37±0.5°C with 
stirring at 50 rpm throughout the experiment. At different 
time interval, 5 ml of aliquots were withdrawn from receiver 
compartment through side tube and analyzed for drug 
content by UV Visible spectrophotometer.  
RESULT AND DISCUSSION 
The preliminary study showed that SA is colorless acicular 
crystals, sweetish acrid taste and odorless powder. It is 
freely soluble in ethanol, methanol and 0.1 N HCl soluble in 
chloroform, slightly soluble in water. The partition 
coefficient of SA was found to be 1.95±0.20. From the FT-IR 
data of the physical mixture it is clear that functionalities of 
drug have remained unchanged including intensities of the 
peak Fig. 1, 2. On the basis of above study it was concluded 
that the solubility in the oils, surfactants and co surfactants 
like Labrasol, Plurol Oleique, neem oil was found to be 
soluble for the microemulsion preparation of SA. The λmax of 
the SA was found to be 251 nm on UV spectrophotometer 
(Shimadzu 1700, Japan), which complies with the official 
literature. The melting point was in the range of 157-1590C 
which is in compliance with the standard value of 158.6 °C as 
per Indian Pharmacopoeia. Compatibility of the drug with 
excipients was determined by differential scanning 
calorimetry (DSC) analysis. This study was carried out to 
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detect any change on chemical constitution of the drug after 
combination with the excipients in the ration (1:1) Fig. 3, 4. 
In formulation of ME system which will be used as drug 
delivery ‘system suitable and optimum oil, surfactant and co-
surfactant need to be chosen. So the solubility of SA in 
various media was analyzed in order to screen components 
of ME. From these results, neem oil, caprylocaproyl macrogol 
glycerides (LAB) and polyglyceryl-6-dioleate (plurol oleique) 
were subsequently used as the oil phase, surfactant and co-
surfactant for the formulation of MEs containing SA in this 
study. Different physicochemical properties of the selected 
oils were studied and were found to be favorable for 
microemulsion drug delivery system. The vesicle size 
analysis of the optimized formulation ME6 was done using 
particle size analyzer. The mean vesicle size was found to be 
16.9±0.3 nm. Zeta potential of the optimized formulation 
ME6 was determined using particle size analyzer. Zeta 
potential of optimized formulation was found to be -
36.99±2.03 mV. Drug content is most important in 
microemulsion formulation and the data found are 
satisfactory. It was found to be 98.56± 2.45to 99.98±1.87% 
which shows the good capacity of formulation to hold the 
drug Table 3, 4. The formulation ME6 having appropriate 
physicochemical parameters, higher permeation parameters 
and a good potential to improve photo stability of SA was 
considered as optimized formulation. The microemulsion 
based gel (MBG) of the optimized formulation was developed 
using a suitable polymer capable of modifying the rheological 
behavior. Four different carbopol gel base prepared for 
optimization (0.5%, 1.0%, 1.5% and 2%) and evaluated for 
pH, spreadability, viscosity measurements and in vitro drug 
release studies. The viscosity of MBG containing 0.5%, 1.0%, 
1.5% and 2% w/w Carbopol 97IP NF were 0.7 ×103 cp, 1.8 
×103 cp, 3.l x 103 cp and 6.5 x 103 cp, respectively. MBG 
containing 0.5% Carbopol 97IP NF had a relatively high 
fluidity. However 2% w/w Carbopol 97IP NF resulted in 
most appropriate fluidity for topical administration. So 2% 
w/w Carbopol 97IP NF as the optimum gel matrix was added 
to ME6 in order to obtain a MBG containing SA. The SA 
content of the MBG was found to 98.97 ± 0.053% w/w of the 
theoretical value (0.05% w/w). Gel spreadability is 
animportant parameter. Application of the formulation on 
inflamed part would be more comfortable if the base spreads 
easily exhibiting maximum slip and drag. When a weighed 
quantity of gel was placed in between two glass plates of 
known weight, it spreaded uniformly to produce a circle, the 
diameter of which is related to its spreadability; the larger 
the diameter, the better the spreadability. The data in table 5 
indicate that the diameter of MBG was 7.2 ± 0.01 cm. While 
the diameter of the marketed gel was found to be 5.8 ± 0.02 
cm indicating that the spreadability of MBG is better than 
that of conventional gel. This is because of the loose gel 
matrix nature of MBG formulation due to the presence of oil 
globules rather than the conventional gel matrix.  In vitro 
drug release study of optimized formulation was carried out 
using modified franz diffusion cell. The optimized 
formulationME6 showed the maximum 67.3% drug release 
in 48 hrs Table 6. 
 
 
Fig. 1 Infrared spectrum of drug sample 
 
 
Fig. 2 Infrared spectrum of drug sample and excipients 
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Fig. 3 DSC Thermo gram of drug sample 
 
Fig. 4 DSC Thermo gram of drug sample and excipients 
Table 3 Physicochemical parameters of salicylic acid loaded microemulsion 
F. Code Particle 
size 
(nm) 
Polydispersity 
index 
Zeta potential 
(mV) 
Drug content 
(%w/w) 
Transmittance (%) 
ME1 72.3±0.4 0.241±0.03 -24.56±2.35 99.12±2.28 98.00±0.63 
ME2 68.5±0.3 0.138±0.05 -29.69±1.75 99.28±2.20 98.17±0.35 
ME3 62.2±0.4 0.243±0.02 -34.42±2.04 99.78±1.67 98.67±0.52 
ME4 44.5±0.7 0.267±0.01 -31.15±2.33 98.56± 2.45 98.35±0.58 
ME5 28.3±0.5 0.186±0.02 -39.42±2.31 99.46±1.85 98.83±0.41 
ME6 16.9±0.3 0.122±0.01 -36.99±2.03 99.98±1.87 99.14±0.52 
 
Table 4 Physicochemical parameters of salicylic acid loaded microemulsion 
F. Code pH Conductivity 
(pS/cm) 
Viscosity 
(cp) 
ME1 6.38±0.08 2.9±0.1 125± 0.09 
ME2 6.55±0.07 13.9±0.8 116±0.02 
ME3 6.65±0.03 31.5±0.6 96±0.08 
ME4 6.70±0.01 67.8±0.5 77±0.01 
ME5 6.41±0.04 128.5±0.3 82±0.02 
ME6 6.89±0.02 205.7±0.5 40±0.05 
 
Table 5 Physicochemical characterization of microemulsion based gel (mean SEM, n=3) 
Parameters MBG 
Drug content (% w/w) 98.97 ± 0.053 
Spreadability (cm) 7.2 ±0.01 
pH 6.2 ±0.03 
Viscosity (cp) 6.5 x 103± 0.2x 103 
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Table 6 In-vitro drug diffusion of microemulsion 
Time 
(Hr) 
In-vitro drug diffusion 
Pure Drug ME6 
1 41.63 19.3 
2 46.27 22.1 
4 48.83 26.4 
6 51.85 31.9 
8 57.14 45.7 
10 65.75 49.8 
12 79.77 55.6 
18 86.75 59.3 
24 99.12 62.6 
48  67.3 
CONCLUSIONS 
This study demonstrates that a microemulsion formulation 
can be used to improve solubility, bioavailability of SA and 
overcome the difficulties associated with its use in the clinic. 
On analysing saturation solubility study result and pseudo 
ternary phase diagram, the oil, surfactant and co surfactant 
were selected. All the prepared formulations exhibited the 
microemulsion properties. The optimized formulation was 
evaluated for zeta potential, globule size analysis and 
stability study. The results suggest that the optimized 
formulation was stable and produced microemulsion. The in-
vitro diffusion study of the formulation was higher as 
compared to pure drug, indicating that the prepared 
formulation is having higher solubility and permeability. 
Thus it can be concluded that microemulsion formulation 
can be used as a one of the formulation technique to enhance 
the bioavailability of the poorly soluble and permeable 
drugs. The present work aimed at developing a successful 
new topical formulation for the delivery of SA was able to 
increase the efficacy of the currently available commercial 
products for the topical treatment of psoriasis. In this study, 
we got success in the development and evaluation of 
microemulsion. Based on higher drug release and lower 
surfactants concentration, higher solubility as well as higher 
bioavailability without variable absorption has been 
optimized as microemulsion formulation of SA as oil, 
surfactants and co-surfactants. The above study leaves a 
future scope for refining technology which can further be 
used for preparation of various other micro/nano systems in 
pharmaceutical products. 
REFERENCES 
1. Schon MP, Boehncke WH. Psoriasis. New England Journal of 
Medicine 2005; 352(18):1899-1912.  
2. Glickman FS. Lepra, psora, psoriasis. Journal of the American 
Academy of Dermatology1986; 14:863-6.  
3. Lo KK, Ho LY. Psoriasis In: Handbook of Dermatology and 
Venereology. HongKong: Social Hygiene Service, Department of 
Health. 1997. 
4. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations 
and immune system changes. Genes and immunity 2007; 8(1):1-
2.  
5. Boehncke WH, Schon MP. Psoriasis. Lancet 2015; 5:983-94. 
6. Collier K, Matalonis S, Owen AJ. Evaluation of permeability 
enhancement by microemulsion in a caco-2 cell system. Proc Int 
Symp Control Release Bioact Mater. 1999; 26:5444-9. 
7. Alany RG, Rades T, Agatonovic-Kustrin S, Dvies NM, Tucker IG. 
Effects of alcohols and diols on the phase behaviour of 
quaternary systems. Int J Pharm. 2000; 196:141-5. 
8. Trotta M, Pattarino F, Grosa G. Formation of lecithin-based 
microemulsions containing n-alkanol phosphocholines. Int J 
Pharm. 1998; 174:253-9. 
9. Marti-MestresG, Nielloud F. Emulsions in health care 
applications- an overview. J Dispers Sci Technol. 2002; 23:419-
39. 
10. Osborne DW, Ward AJ, O’Neill KJ. Microemulsions as topical drug 
delivery vehicles: in-vitro transdermal studies of a model 
hydrophilic drug. J Pharm Pharmacol Comm. 1991; 43:451-4. 
11. Jachowicz J, Berthiaume MD. Microemulsions vs. 
macroemulsions in hair care products. Cosmet Toiletries. 1993; 
108:65-72. 
12. Orth DS, Widjaja J, Ly L, Cao N, Shapiro WB. Stability and skin 
persistence of topical products: evaluating the effect of a 
hydroalcoholichydroquinone vehicle. Cosmet Toiletries 1998; 
113 (10):51-63. 
13. Reynolds JEF, editor. Martindale, the extra pharmacopoeia, 30th 
edition. London: The Pharmaceutical Press; 1993.  
14. Bashir SJ, Dreher F, Chew AL, Zhai H, Levin C, Stern R, et al. 
Cutaneous bioassay of salicylic acid as a keratolytic. Int J Pharm. 
2005; 292:187-94. 
15. Park WB, Kim SH, Cho JH, Bang JH, Kim HB, Kim NJ, et al. Effect of 
salicylic acid on invasion of human vascular endothelial cells by 
Staphylococcus aureus. FEMS Immunol Med Microbiol. 2007; 
49:56-61.  
16. Kupferwasser LI, Yeaman MR, Nast CC, Kupferwasser D, Xiong 
YQ, Palma M, et al. Salicylic acid attenuates virulence in 
endovascular infections by targeting global regulatory pathways 
in Staphylococcus aureus. J Clin Invest. 2003; 112(2):222-33. 
17. British Medical Association and the Royal Pharmaceutical 
Society of Great Britain. British National Formulary, No. 26; 
1993. p. 408-10. 
18. Patel MR, Patel RB, Parikh JR, Solanki AB, Patel BG. Effect of 
formulation components on the in vitro permeation of 
microemulsion drug delivery system of fluconazole. AAPS 
PharmSciTech. 2009; 10: 917-923. 
19. Patel MR, Patel RB, Parikh JR, Solanki AB. Investigation of 
efficiency of isopropyl myristate-based oil in water 
microemulsions for topical delivery of fluconazole. Int Biomed 
Phann Sci. 2009; 3: 60-68. 
20. Djordjevic L, Primorac M, Stupar M, Krasjinik D. Characterization 
of caprylocaproyi macrogolglycerides based microemulsion 
drug delivery vehicles for an amphiphilic drug. Int J Pharm. 
2004; 271:11-19. 
21. Li L, Nandi I, Kim KH. Development of an ethyl laurate-based 
microemulsion for rapid-onset intranasal delivery of diazepam. 
Int J Pharm. 2002; 237: 77-85. 
22. Ghosh PK, Majithiya RJ, Umrethia ML, Murth RSR. Design and 
development of microemulsion drug delivery system of 
acyclovir for improvement of oral bioavailability. AAPS Pharm 
Sci Tech. 2006; 7 (3):Article 77. 
23. Ghosh PK, Majithiya RJ, Umrethia ML, Murth RSR. Preparation 
and characterization of caprylocapryl macrogol -8- glycerides 
microemulsion for pral drug delivery. Ars Pharm. 2004; 
45(3):353-372. 
24. Zhu W, Aihua YU, Wang W, Dong R, Wu J. Formulation design of 
microemulsion for dermal delivery of penciclovir. Int J Pharm. 
2008; 360:184-190. 
25. Biruss B, Valenta C. Skin permeation of different steroid 
hormones from polymeric coated liposomal formulations. Eur J 
Pharm Biopharm. 2006; 62: 210-219. 
26. Biruss B, Valenta C. The advantage of polymer addition to a non-
ionic ails in water microemulsion for the dermal delivery of 
progesterone. Int J Pharm. 2008; 349: 269-273. 
 
 
 
 
